This result provides evidence supporting the potential diagnostic value of plasma TDP‐43 for ALS as well as the usefulness of such new digital analytical platforms for the development of blood–based biomarkers of the disease. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.